Chemours (CC) Payables (2014 - 2026)

Chemours has reported Payables for 13 years, with the latest figure at $937.0 million in Q2 2026.

• On a quarterly basis, Payables fell 8.41% year-over-year to $937.0 million in Q2 2026; TTM through Jun 2026 was $937.0 million, a 8.41% decrease from a year earlier, with the FY2025 full-year figure at $954.0 million, down 17.47% from the prior year.
• Payables was $937.0 million for Q2 2026 at Chemours, up from $891.0 million in the prior quarter.
• The five-year high for Payables was $1.3 billion in Q3 2022, with the low at $885.0 million in Q3 2023.
• Average Payables over 5 years is $1.1 billion, with a median of $1.0 billion recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Payables tumbled 30.31% in 2023, then grew 21.81% in 2024.
• Over 5 years, Payables stood at $1.2 billion in 2022, then dropped by 6.0% to $1.2 billion in 2023, then decreased by 0.26% to $1.2 billion in 2024, then slipped by 17.47% to $954.0 million in 2025, then dropped by 1.78% to $937.0 million in 2026.
• The last three Payables figures came in at $937.0 million (Q2 2026), $891.0 million (Q1 2026), and $954.0 million (Q4 2025), per Business Quant data.